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ABSTRACT
Low biomass microbiome has an increasing importance in today’s fertility studies. There are more and more indications 
for incorporating upper gynecological tract microbiome content in patients diagnostic and in vitro fertilization process, as 
doing so may help to evaluate chances for a positive outcome. An abnormal endometrial microbiota has been associated 
with implantation failure, pregnancy loss, and other gynecological and obstetrical conditions. Furthermore it has been 
shown, that using molecular methods in addition to routine diagnostics may help diagnose chronic endometritis or even 
indicate cancerogenic changes. Understanding the significance of microbiome in endometrium may completely change 
therapeutic approach in treatment of this part of reproductive tract. Next generation sequencing (NGS) has allowed to 
isolate culturable and unculturable bacteria from female reproductive tract and is a cheaper and quicker alternative for 
other widely known and used methods.
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INTRODUCTION
For almost a century gynecologists and scientists were 
convinced that a healthy uterus is sterile. Henry Tissier, who 
in early 1930’s has isolated bacteria from the stool of healthy 
breastfed infants, believed that an infant develops in a sterile 
womb and its first contact with the bacteria occurs during 
entering the birth canal [1, 2]. Further studies on this subject 
has shown that meconium is not sterile, and bacteria were 
also detected in amniotic fluid, umbilical cord and fetal mem-
branes of healthy term babies [3–6]. These findings prompted 
further research as more proof of nonsterile fetus cast doubt 
on the assumption of has no commensal microflora in the 
upper genital tract. The importance of microbiome in the 
entire fetal life is currently studied by many researchers [7]. 
UTERINE MICROBIOME 
Until very recent, the cervix had been seen as a perfect 
barrier between the vagina, uterus and the fallopian tubes, 
which were believed to be sterile. However, some studies 
have proven, that the changes in relative concentration of 
mucins present in the cervix, are leading to changes in their 
aggregation. Such changes dependent on pH variations 
during menstrual cycle and may allow bacteria passage 
under certain conditions [8].
In 1995 Moller et al. [9] published a study describing 
bacterial culture isolated from the cervix and the uterus of 
99 patients undergoing a hysterectomy, where main indica-
tions for the procedure were persistent vaginal bleeding 
(n = 29) and fibromyomas of the uterus (n = 34). 26 of the 
studied patients were culture-negative for all microorgan-
isms based on the samples from the apex of the vagina and 
the cervical os. The team has managed to isolate bacteria 
from the uterine cavity samples in 24 out of 99 analyzed 
cases. The most common pathological organism isolated 
from the vagina was G.vaginalis. It was found in 45.5% of 
culture-positive women. Other frequently isolated bacteria 
were S.agalactiae and Enterobacter spp. found in in 15% of 
the cases. Among the 24 patients with a positive culture 
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from the uterine cavity G.vaginalis was isolated in 11 cases 
and S.agalactiae in 5 cases. The team has concluded that the 
uterine cavity is contaminated with microorganisms in a sig-
nificant number of patients admitted for hysterectomies. It 
has been recommended to send the endometrium biopsy 
samples for histological and microbiological testing prior to 
the hysterectomy [9].
The result of this and many other studies have shown, 
that there is a microbiota continuum along the female 
reproductive tract. The lower third of vagina, and poste-
rior fornix are dominated by Lactobacillus spp .(99.99%). 
However, samples taken from cervical canal contain lower 
proportion of Lactobacillus spp. (97.56%) than the vaginal 
samples [9, 10]. According to the study by Chen et al., Lac-
tobacillus spp. is not a dominant genus in the endometrial 
samples (30.6%). Bacteria such as Acinetobacter (9.07%), 
Pseudomonas (9.09%), Sphingobium (5%) and Vagococcus 
(7.29%) form a large portion of endometrial microbiome. 
At the openings of the fallopian tubes the proportion of 
these bacteria increases while the median relative amount 
of Lactobacillus spp. is around 1,69%, and peritoneal fluid 
from the pouch of Douglas contains little to no Lactobacil-
lus genus [10–12].
Next generation sequencing (NGS) has enabled a far 
more global evaluation of bacterial composition of the uterus 
as it cannot be measured with culture dependent meth-
ods. In the year 2000 Drancourt et al. [13], made several rec-
ommendations concerning proposed criteria for 16S rDNA 
gene sequencing as a reference method for bacterial iden-
tification. In further studies however it has been observed 
that the 16S rDNA is not a perfect target for NGS analysis and 
bacteria identification. Genomic DNA isolated from a sample 
contains random fragments of bacterial genomes and can be, 
potentially, contaminated by host DNA or DNA of other 
organisms present in this sample [14]. 16S RNA amplicon 
sequencing can be targeted specifically against bacteria. It 
also does not require the availability of reference genome 
sequences. Furthermore it can be used in cases where only 
trace amount or poor quality bacterial DNA templates are 
accessible [15, 16]. Therefore 16S rRNA sequencing became 
a standard method in bacterial community profiling.
It is important to highlight that the differences between 
the endometrial and vagina microbiome have been ob-
served regardless of the method of collection of endome-
trial samples, which confirms the existence of indigenous 
endometrial microbiota and shows that the vaginal – cervi-
cal canal is a safe route for sampling the uterine cavity for 
further microbiome analysis [12, 17, 18]. 
The role of immune system in uterus colonization cannot 
be forgotten. Studies have shown that the endometrial fluid 
and the uterine mucosal surface contain infection-control-
ling molecules, known as antimicrobial peptides (AMPs), 
with changing levels during the menstrual cycle [19]. AMPs 
are contributing to female reproductive tract health with 
implication for fertility and pregnancy [20]. The secretory 
leukocyte protease inhibitor, which has antiviral and an-
tifungal properties, is present in the uterus. It acts against 
gram — negative bacteria such as E.coli and gram-positive 
bacteria such as S. aureus [21]. Givan et al. [22], has shown 
presence of the lymphocytes in the mucosal layer, ready to 
act upon pathogen invasion, throughout all stages of the 
menstrual cycle. We can, therefore, assume that the uterus 
could offer a safe niche for symbiotic colonization.
Koedooder et al. [23] has proposed semen to be an-
other possible route of introducing microbiota into female 
reproductive tract. His studies have shown, that the male 
and female microbiome are influenced by each other and 
seem to interact [23]. How the two interact is still unknown. 
Future research could resolve the question of the exist-
ence of temporary female-male microbiome forms during 
post-coital period and its influence on conception. 
Current data suggest that the importance and confir-
mation of natural presence of healthy uterine microbiota 
need to be assessed by well-setup large cohort studies [24].
INFLUENCE ON REPRODUCTION AND 
WOMEN’S HEALTH
There are some indications that uterine microbiome 
might influence endometrial receptivity. Early prospective 
studies considering the role of endometrial microbial colo-
nization suggested that positive microbiological endome-
trial culture, obtained from the tip of the transfer catheter 
in patients undergoing in vitro fertilization, had negative 
effects on implantation and pregnancy rates. The transfer 
catheter tip or cervical smear culture positive for bacteria 
strains such as: Enterobacteriaceae spp., Streptococcus spp., 
Staphylococcus spp., Escherichia coli, was associated with 
decreased implantation rate and poor pregnancy outcome 
[25–27]. For example, Selman et al. have designed prospec-
tive clinical trial including 152 patients undergoing IVF pro-
cedure. Separate samples for microbial examination, were 
taken during embryo transfer from the vagina, the cervix 
and culture medium: prior and post-embryo transfer. Of 
the 152 patients, 133 tested positive for one or more micro-
organisms, and the remaining 19 patients tested negative 
in all samples taken. In the positive group the microorgan-
isms identified were as follows: Enterobacteriaceae in 99 pa-
tients, Streptococcus spp. in 43 patients, Staphylococcus spp. 
in 68 patients, Lactobacillus in 19 patients and other species 
such as: S.agalactiae, G.vaginalis, Ureaplasma urealyticum 
and yeast in 28 patients. Pregnancy rates were significantly 
lower in patients positive with Enterobacteriaceae culture 
and Staphylococcus (in compare with negative culture group 
(22.2% vs 51% and 17.6% vs 43% respectively) [26].
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Those results have been confirmed by Moreno et al. [18] 
study where patients were divided into two general groups: 
LD (Lactobacillus Dominant; > 90%) and NLD (non-Lactoba-
cillus Dominant; < 90%). The analysis of endometrial micro-
biota showed significant differences in the bacterial diversity 
in the NLD group. This group, in comparison with the LD 
group, also had significantly lower implantation (23.1% 
vs 60.7%, p = 0.02), pregnancy (33.3% vs 70.6%, p = 0.03), 
ongoing pregnancy (13.3% vs 58.8%, p = 0.02), and live birth 
(6.7% vs 58.8% p = 0.002) rates.
Genus Lactobacillus is a very important component in 
major part of the uterine microbiome studies. However, 
comparison of the relative abundance of Lactobacillus 
between sequencing reports underline the inconsistency 
among reports and needs further investigation [28–30]. 
Fang et al. [31] described higher levels of Lactobacillus in 
the group of women with endometrial polyps or in women 
with chronic endometriosis coexisting with endometrial 
polyps, compared with healthy control. By contrast, the 
work of Moreno et al., reported that high levels of Lactoba-
cillus (over 90% as defined by the group) are significantly 
associated with growing reproductive success in women 
undergoing IVF. Nevertheless, it has not been determined, 
which species of Lactobacillus may be capable of conferring 
this benefit [18].
In other studies, the increased reproductive success in 
women with high level of Lactobacillus may have reflected 
the composition of the vaginal microbiome at the time of 
embryo transfer [28]. Haahr et al. have tested 130 patients 
undergoing IVF treatment. PCR analysis for G.vaginalis, 
A.vaginae, L. crispatus, L. jensenii, L.gasseri and L.iners were 
performed. Dominance of Lactobacillus spp. was interpreted 
as normal, whereas bacterial vaginosis was diagnosed if the 
G.vaginalis and/or A.vaginae were dominating. Eighty-four 
patients completed IVF treatment and overall clinical 
pregnancy rate was 35% (29/84). Interestingly, only 2 of 
22 patients with abnormal vaginal microbiota obtained 
pregnancy (p = 0.004) [30]. Even though the microbial 
uterine environment plays a role in the implantation and 
placentation process, it is mainly tightly regulated by female 
sex hormones. 
Therefore Moreno et al. [18] has evaluated IVF catheter 
tips at two different time points. One sample was taken at 
the pre receptive phase and the other at the receptive phase 
of the same menstrual cycle to asses shift in microbiome 
composition in IVF patients. This study has indicated, that 
the uterine microbiome was similar at both time points in 
9 out of 13 patients sampled, which is similar to the vaginal 
microbiome changes in the same time window [18, 32].
Recent reports from Moreno et. al demonstrates, that 
molecular microbiology is a reliable, fast, and cheap diag-
nostic tool that allows for the detection of culturable and 
non-culturable bacteria associated with chronic endometritis 
and has 77% concordance with a combination of the classi-
cal diagnostic methods such as histology, hysteroscopy and 
microbial culture [10]. This is very important information, as 
chronic endometritis can be asymptomatic, and is found in 
about 40% of infertile patients, likely causing repeated im-
plantation failure or even recurrent miscarriage [10]. The study 
includes a small study group (65 patients), which indicates 
that more research has to be done to confirm those findings.
Pathological changes in endometrial microbiota may 
play an important role in carcinogenesis [33, 34]. There are 
some hypothesis that the pelvic inflammatory disease (PID) 
may result from pathogenic bacteria ascendance through 
the cervix into the upper genital tract and cause inflamma-
tion of the uterus, fallopian tubes and/or ovaries [34, 35]. 
Carcinogenesis on the other hand may occur when the 
tumor-associated loss of bacteria function causes increased 
commensal penetration and inflammation induction, which 
in turn result in enhance tumor growth. Other possibility is 
so called: pathobiont-mediated tumorigenesis, by which 
potentially pathogenic commensal strains are creating tu-
morigenic environment by secreting mediators [36]. 
IMPLICATIONS FOR THE FUTURE
If bacteria are naturally present in the womb, their im-
portance not only in terms of fertility, but also in mainte-
nance of the uterus deserves attention. 
In the future, the targeted elimination of cancer — as-
sociated with microorganisms might provide a new therapy 
option. It seems to be a very attractive alternative because 
of its minimal expected side effects and the possibility of its 
preventive application. Studying the interactions between 
host and endometrial microenvironment may open new 
diagnostic possibilities and help to prevent consequences of 
serious diseases. It may also help us better understand the role 
of microbiome in implantation process and suggest routes to 
achieve positive outcome in infertility treatment. Molecular 
methods are shown to be a very powerful tool in defining the 
role of endometrial microbiome in women’s health.
CONCLUSIONS
Thanks to next generation sequencing (NGS), endome-
trial microbiome is becoming better characterized and its 
importance in gynecologic and reproductive health is increas-
ing. However, researchers have not yet reached a consensus, 
whether an altered microbiome is a cause or an effect of up-
per gynecological tract diseases. More research is needed to 
describe and understand the role of endometrial microbiome 
in endometrial receptivity and the outcome of in vitro ferti-
lization. For optimal success, further studies require well-de-
signed experiments and larger patient groups to explain the 
interactions between host microbiome and women’s health.
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et pathologique. G Carré et C Naud, Paris 1900.
2. Weiss JE, Rettger LF. Taxonomic Relationships of Lactobacillus Bifidus 
(B. Bifidus Tissier) and Bacteroides Bifidus. Journal of Infectious Dis-
eases. 1938; 62(1): 115–120, doi: 10.1093/infdis/62.1.115.
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